These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 16540033)

  • 1. [Relationship between C-reactive protein level and early recurrence of atrial fibrillation after electrical cardioversion].
    Zarauza J; Rodríguez Lera MJ; Fariñas Alvarez C; Hernando JP; Ceballos B; Gutiérrez B; Pérez J; Cuesta JM
    Rev Esp Cardiol; 2006 Feb; 59(2):125-9. PubMed ID: 16540033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.
    Loricchio ML; Cianfrocca C; Pasceri V; Bianconi L; Auriti A; Calo L; Lamberti F; Castro A; Pandozi C; Palamara A; Santini M
    Am J Cardiol; 2007 May; 99(10):1421-4. PubMed ID: 17493472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion.
    Watanabe E; Arakawa T; Uchiyama T; Kodama I; Hishida H
    Int J Cardiol; 2006 Apr; 108(3):346-53. PubMed ID: 15964643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation.
    Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Kolyvaki SG; Lyrarakis GM; Chlouverakis GI; Vardas PE
    Heart; 2008 Feb; 94(2):200-4. PubMed ID: 17575330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion.
    Henningsen KM; Therkelsen SK; Bruunsgaard H; Krabbe KS; Pedersen BK; Svendsen JH
    Scand J Clin Lab Invest; 2009; 69(3):425-32. PubMed ID: 19204850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of sinus rhythm restoration on high-sensitivity C-reactive protein levels and their association with long-term atrial fibrillation recurrence after electrical cardioversion.
    Celebi OO; Celebi S; Canbay A; Ergun G; Aydogdu S; Diker E
    Cardiology; 2011; 118(3):168-74. PubMed ID: 21654170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High sensitivity C-reactive protein: a novel predictor for recurrence of atrial fibrillation after successful cardioversion.
    Malouf JF; Kanagala R; Al Atawi FO; Rosales AG; Davison DE; Murali NS; Tsang TS; Chandrasekaran K; Ammash NM; Friedman PA; Somers VK
    J Am Coll Cardiol; 2005 Oct; 46(7):1284-7. PubMed ID: 16198844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein but not atrial dysfunction predicts recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.
    Lombardi F; Tundo F; Belletti S; Mantero A; Melzi D'eril GV
    J Cardiovasc Med (Hagerstown); 2008 Jun; 9(6):581-8. PubMed ID: 18475126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term prognostic value of baseline C-reactive protein in predicting recurrence of atrial fibrillation after electrical cardioversion.
    Korantzopoulos P; Kalantzi K; Siogas K; Goudevenos JA
    Pacing Clin Electrophysiol; 2008 Oct; 31(10):1272-6. PubMed ID: 18811807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predictive value of plasma brain natriuretic peptide for the recurrence of atrial fibrillation six months after external cardioversion.
    Ari H; Binici S; Ari S; Akkaya M; Koca V; Bozat T; Gürdoğan M
    Turk Kardiyol Dern Ars; 2008 Oct; 36(7):456-60. PubMed ID: 19155659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study.
    Wozakowska-Kapłon B; Opolski G
    Int J Cardiol; 2004 Aug; 96(2):171-6. PubMed ID: 15262030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of electrical cardioversion on inflammation and indexes of structural remodeling, in persistent atrial fibrillation.
    Climent V; Marín F; Mainar L; Roldán V; García A; Martínez JG; Lip GY
    Int J Cardiol; 2009 Feb; 132(2):227-32. PubMed ID: 18234374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordant regulation of CRP and NT-proBNP plasma levels after electrical cardioversion of persistent atrial fibrillation.
    Buob A; Jung J; Siaplaouras S; Neuberger HR; Mewis C
    Pacing Clin Electrophysiol; 2006 Jun; 29(6):559-63. PubMed ID: 16784419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-3 polyunsaturated fatty acids administration does not reduce the recurrence rates of atrial fibrillation and inflammation after electrical cardioversion: a prospective randomized study.
    Ozaydın M; Erdoğan D; Tayyar S; Uysal BA; Doğan A; Içli A; Ozkan E; Varol E; Türker Y; Arslan A
    Anadolu Kardiyol Derg; 2011 Jun; 11(4):305-9. PubMed ID: 21543294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
    Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A
    Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension and paroxysmal atrial fibrillation: a novel predictive role of high sensitivity C-reactive protein in cardioversion and long-term recurrence.
    Rizos I; Rigopoulos AG; Kalogeropoulos AS; Tsiodras S; Dragomanovits S; Sakadakis EA; Faviou E; Kremastinos DT
    J Hum Hypertens; 2010 Jul; 24(7):447-57. PubMed ID: 20072146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The contribution of inflammatory process in pathogenesis and natural history of atrial fibrillation].
    Zyśko D; Gajek J; Mazurek W
    Pol Merkur Lekarski; 2005 Feb; 18(104):227-8. PubMed ID: 17877137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of atrial fibrillation recurrence rates after successful electrical cardioversion in patients with hyperthyroidism-induced versus non-hyperthyroidism-induced persistent atrial fibrillation.
    Siu CW; Jim MH; Zhang X; Chan YH; Pong V; Kwok J; Kung AW; Lau CP; Tse HF
    Am J Cardiol; 2009 Feb; 103(4):540-3. PubMed ID: 19195517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial natriuretic peptide before and after cardioversion of persistent atrial fibrillation.
    Wozakowska-Kapłon B; Opolski G; Janion M
    Kardiol Pol; 2003 Apr; 58(4):255-63. PubMed ID: 14517556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of interleukin-6 and C-reactive protein levels to sinus maintenance after pharmacological cardioversion in persistent atrial fibrillation.
    Fujiki A; Sakamoto T; Nishida K; Mizumaki K; Inoue H
    J Cardiovasc Pharmacol; 2007 Sep; 50(3):264-6. PubMed ID: 17878753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.